Table 3 Percentage of the surveyed physicians answering in line with the ARIA México 2014 recommendations/suggestions on the 2 nd part of the treatment of allergic rhinitis: glucocorticosteroids (ARIA Guideline, Block 4)
Clinical questions Block 4: Treatment of Allergic rhinitis without asthma: glucocorticosteroids | ARIA México 2014# | % of physicians with the ‘correct’ answer## | ||||
|---|---|---|---|---|---|---|
Allergists | ENTs | Pulm | Peds | GPs | ||
19. Should intranasal glucocorticosteroids be used for treatment of AR? | R: Yes (adult) | 97 | 97 | 96 | 91 | 83*** |
S: Yes (child) | ||||||
20. Should intranasal gluco-corticosteroids (GCS) versus oral H1-antiH be used in patients with AR?. | S: inGCS | 73 | 61 | 88 | 76 | 53*** |
21. Should intranasal GCS versus intranasal H1-antiH be used in patients with AR? | R: inGCS | 92 | 88 | 92 | 90 | 66*** |
22. Should intranasal GCS versus oral leukotriene receptor antagonists be used for treatment of AR? | R: inGCS | 90 | 82 | 84 | 75*** | 70*** |
23. Should oral GCS be used for treatment of AR in patients not responding to other therapy? | S: yes, short | 87 | 87 | 73* | 72** | 72** |
24. Should intramuscular GCS be used for treatment of AR? | R: no | 88 | 60*** | 88 | 95 | 88 |